Murase T, Nakamura S
Department of Hematology, Toyota Memorial Hospital, Japan.
Leuk Lymphoma. 1999 May;33(5-6):459-73. doi: 10.3109/10428199909058451.
Malignant histiocytosis-like B-cell lymphoma (MH-like BCL) is characterized clinically by hemophagocytic syndrome (HPS), bone marrow involvement at presentation, and an aggressive clinical course. Yet, it remains an ill-defined disease entity. We recently described five cases of MH-like BCL and suggested that these may be regarded as a peculiar variant of intravascular lymphomatosis (IVL), based on clinical and pathological observation. Interestingly, this type of lymphoma has been reported exclusively among Asians, with few reports from Western countries, and therefore we propose that this variant be noted as an Asian variant of IVL(AIVL). To evaluate the incidence of this variant, we performed a literature search for English or Japanese studies dealing with MH-like BCL or B-cell IVL associated with HPS (IVL with HPS). We found 18 reports of MH-like BCL and 16 reports of IVL with HPS and re-evaluated the clinicopathologic aspects of each study with respect to AIVL. Although several differences were noted, such as gender, presence of respiratory changes, bone marrow invasion and disseminated intravascular coagulopathy, there were also overlapping profiles and they appeared to be consistent with the AIVL single disease entity. Of particular note was the absence of peripheral lymphadenopathy and tumor formation which posed diagnostic problems in the initial phase of the presentations. Thus, based on analysis of the clinical findings of these 34 cases, the diagnostic criteria for AIVL consists primarily of cytopenia (anemia and/or thrombocytopenia), hepatosplenomegaly, absence of peripheral lymphadenopathy and tumor formation, and erythrocyte-hemophagocytosis along with intravascular proliferation of the neoplastic B cells. The pathologic findings of the 19 autopsied cases which fulfilled the criteria are also summarized, and they reveal morphologic, immunologic, and genotypic features of typical IVL.
恶性组织细胞增多症样B细胞淋巴瘤(MH样BCL)的临床特征为噬血细胞综合征(HPS)、初诊时骨髓受累以及侵袭性临床病程。然而,它仍是一种定义不明确的疾病实体。我们最近描述了5例MH样BCL病例,并基于临床和病理观察提出,这些病例可能被视为血管内淋巴瘤(IVL)的一种特殊变体。有趣的是,这种类型的淋巴瘤仅在亚洲人中被报道过,西方国家鲜有报告,因此我们建议将这种变体记为IVL的亚洲变体(AIVL)。为评估这种变体的发病率,我们对涉及MH样BCL或与HPS相关的B细胞IVL(伴有HPS的IVL)的英文或日文研究进行了文献检索。我们找到了18篇关于MH样BCL的报告和16篇关于伴有HPS的IVL的报告,并重新评估了每项研究中与AIVL相关的临床病理方面。尽管注意到了一些差异,如性别、呼吸变化的存在、骨髓浸润和弥散性血管内凝血,但也有重叠的特征,它们似乎与AIVL单一疾病实体一致。特别值得注意的是,在疾病初期没有外周淋巴结病和肿瘤形成,这给诊断带来了问题。因此,基于对这34例病例临床发现的分析,AIVL的诊断标准主要包括血细胞减少(贫血和/或血小板减少)、肝脾肿大、无外周淋巴结病和肿瘤形成,以及红细胞吞噬现象和肿瘤性B细胞的血管内增殖。还总结了符合标准的19例尸检病例的病理发现,它们揭示了典型IVL的形态学、免疫学和基因型特征。